Literature DB >> 15197711

Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology.

Sean J Pittock1, Timothy Parrett, Charles H Adler, Joseph E Parisi, Dennis W Dickson, J Eric Ahlskog.   

Abstract

The neuroanatomical substrate for restless legs syndrome (RLS) is unknown. We identified 4 patients with idiopathic RLS who came to post-mortem examination, where brain and spinal cord tissue were available for neuropathological assessment. Lewy bodies were not identified and alpha-synuclein immunohistochemistry was uniformly negative. Neurofibrillary tangle pathology was variable and nonspecific. These findings suggest that tau- or alpha-synuclein brain pathology is not a component of primary RLS. Although chronic ischemic changes were found in all 4 cases, these were probably incidental. The absence of diagnostic microscopic brain or spinal cord pathology suggests that the pathologic substrate may be neurochemical or receptor based. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197711     DOI: 10.1002/mds.20042

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

Review 1.  Pathophysiology of restless legs syndrome: evidence for iron involvement.

Authors:  James R Connor
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

Review 2.  [Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].

Authors:  S Happe; W Paulus
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

3.  Periodic Leg Movements in Sleep and Restless Legs Syndrome: Considerations in Geriatrics.

Authors:  Donald L Bliwise
Journal:  Sleep Med Clin       Date:  2006-06-01

4.  Evaluating and Managing Sleep Disorders in the Parkinson's Disease Clinic.

Authors:  S Gulyani; R Salas; Z Mari; S Choi; A Mahajan; C Gamaldo
Journal:  Basal Ganglia       Date:  2016-05-27

Review 5.  Therapies for Restless Legs in Parkinson's Disease.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2019-11-09       Impact factor: 3.598

6.  Genetic markers of Restless Legs Syndrome in Parkinson disease.

Authors:  Ziv Gan-Or; Roy N Alcalay; Anat Bar-Shira; Claire S Leblond; Ronald B Postuma; Shay Ben-Shachar; Cheryl Waters; Amelie Johnson; Oren Levy; Anat Mirelman; Mali Gana-Weisz; Nicolas Dupré; Jacques Montplaisir; Nir Giladi; Stanley Fahn; Lan Xiong; Patrick A Dion; Avi Orr-Urtreger; Guy A Rouleau
Journal:  Parkinsonism Relat Disord       Date:  2015-03-17       Impact factor: 4.891

7.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 8.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

9.  Restless legs syndrome in multiple system atrophy.

Authors:  Imad Ghorayeb; Sandrine Dupouy; François Tison; Wassilios G Meissner
Journal:  J Neural Transm (Vienna)       Date:  2014-05-13       Impact factor: 3.575

10.  Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.

Authors:  Tasneem Peeraully; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2012-02-27       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.